1. Comparison of basic information on the two versions of the GMP
2. Comparison of key differences in core content: quality management philosophy
1. From “process control” to “whole-life-cycle risk governance”
2. Organisation and personnel: from a “vague framework” to “tiered qualifications + independent performance of duties”
3. Production facilities control: from “basic requirements” to “quantified standards + digital and intelligent adaptation”
4. Digitalisation and traceability: from “no requirements” to “mandatory implementation”
The new GMP is not a simple patch of the 2014 version but a systematic upgrade built around three core goals: “whole-life-cycle regulation”, “digital and intelligent transformation” and “clear responsibilities”. From the broad expansion of the quality management philosophy, to quantified standards for key positions and production facilities, to filling gaps in areas such as contract manufacturing and validation, every change targets long-standing management pain points in the medical device industry.
For companies, the November 2026 implementation date is not just a compliance deadline but a key opportunity to align their quality management systems with the industry’s requirements for high-quality development. They need to plan ahead and adapt proactively.
About EVERBIZ: your medical device compliance management partner
More articles:
Getting Started with Japan PSE Certification | History and Product Categories Explained
Exporting Veterinary Medical Equipment to the US: Compliance Requirements Explained!
The EU AI Act and Its Application Under the MDR
Key Compliance Points for Biosafety Cabinets Under GB 41918-2022